Diabetic Medicine 2012; 29(5): 690-692

Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

K.Y. Thong, M.L. Cull,  R.E.J. Ryder, C. Walton, on behalf of the ABCD nationwide exenatide and liraglutide audit contributors.

1City Hospital, Birmingham, UK

2Hull Royal Infirmary, Hull, UK